Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| NOVACEA INC | 228,750 | reported | 21 Sept 2023 | tx 65+4,027,479−1,814,656 |
| SUPERNUS PHARMACEUTICALS, INC. | 25,000 | reported | 22 Mar 2013 | tx 5+43,722 |
| XENOGEN CORP | 0 | reported | 09 Aug 2006 | tx 20+1,736,483−5,264,192 |
| Frazier Lifesciences Acquisition Corp | 0 | reported | 22 Nov 2022 | tx 1−30,000 |
| Adamas Pharmaceuticals Inc | 0 | reported | 24 Nov 2021 | tx 12+95,000−40,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Feb 2018 | EXERCISE | NOVACEA INC | 23,255 | 4.30 USD | |
| 21 Sept 2023 | OTHER | NOVACEA INC | 1,129,282 | — | |
| 21 Sept 2023 | OTHER | NOVACEA INC | 228,750 | — | |
| 02 Feb 2018 | EXERCISE | NOVACEA INC | 23,225 | 0.00 USD | deriv |
| 08 Aug 2023 | GRANT_AWARD | NOVACEA INC | 156,250 | 0.00 USD | |
| 09 Aug 2023 | SALE | NOVACEA INC | 31,250 | 2.20 USD | |
| 20 Dec 2022 | GRANT_AWARD | NOVACEA INC | 45,000 | 0.00 USD | |
| 21 Dec 2022 | SALE | NOVACEA INC | 15,750 | 1.99 USD | |
| 13 Dec 2022 | SALE | NOVACEA INC | 31,891 | 1.96 USD | |
| 12 Dec 2022 | SALE | NOVACEA INC | 19,484 | 1.98 USD | |
| 22 Nov 2022 | EXERCISE | Frazier Lifesciences Acquisition Corp | 30,000 | — | deriv |
| 28 Oct 2022 | SALE | NOVACEA INC | 6,000 | 3.47 USD | |
| 25 Oct 2022 | GRANT_AWARD | NOVACEA INC | 30,000 | 0.00 USD | |
| 09 Aug 2022 | SALE | NOVACEA INC | 28,637 | 2.66 USD | |
| 08 Aug 2022 | GRANT_AWARD | NOVACEA INC | 143,182 | 0.00 USD | |
| 15 Mar 2022 | GRANT_AWARD | NOVACEA INC | 202,500 | 0.00 USD | |
| 15 Dec 2021 | SALE | NOVACEA INC | 17,819 | 4.27 USD | |
| 14 Dec 2021 | SALE | NOVACEA INC | 8,622 | 4.37 USD | |
| 13 Dec 2021 | SALE | NOVACEA INC | 5,059 | 4.42 USD | |
| 24 Nov 2021 | TENDER | Adamas Pharmaceuticals Inc | 10,000 | — | |
| 24 Nov 2021 | OTHER | Adamas Pharmaceuticals Inc | 10,000 | — | deriv |
| 24 Nov 2021 | OTHER | Adamas Pharmaceuticals Inc | 10,000 | — | deriv |
| 24 Nov 2021 | OTHER | Adamas Pharmaceuticals Inc | 10,000 | — | deriv |
| 16 Aug 2021 | GRANT_AWARD | NOVACEA INC | 75,000 | 0.00 USD | |
| 17 Aug 2021 | SALE | NOVACEA INC | 32,030 | 5.12 USD |
1 purchase reported after at least 12 months of silence — most recent on 23 Jun 2016.